FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3183282470> ?p ?o ?g. }

• W3183282470 endingPage "1368" @default.
• W3183282470 startingPage "1360" @default.
• W3183282470 abstract "Uncertainty about the benefit-risk ratio of regional lymph node irradiation led to varying clinical protocols. We investigated long-term late side effects after internal mammary and medial supraclavicular (IM-MS) lymph node irradiation to improve shared decision making.The multicenter European Organization for Research and Treatment of Cancer trial (ClinicalTrials.gov, NCT00002851) randomly assigned stage I-III breast cancer patients with involved axillary nodes and/or a medially located primary tumor. We analyzed late side effects both longitudinally at every follow-up and cross-sectionally at 5-year intervals. All statistical tests were 2-sided.Between 1996 and 2004, 46 departments from 13 countries accrued 4004 patients. Median follow-up was 15.7 years. Longitudinal follow-up data showed cumulative incidence rates at 15 years of 2.9% (95% confidence interval [CI] = 2.2% to 3.8%) vs 5.7% (95% CI = 4.7% to 6.9%) (P < .001) for lung fibrosis, 1.1% (95% CI = 0.7% to 1.7%) vs 1.9% (95% CI = 1.3% to 2.6%) (P = .07) for cardiac fibrosis, and 9.4% (95% CI = 8.0% to 10.8%) vs 11.1% (95% CI = 9.6% to 12.7%) (P = .04) for any cardiac disease when treated without or with IM-MS lymph node irradiation. There was no evidence for differences between left- and right-sided breast cancer (Wald χ2 test of treatment by breast side interaction, P = .33 and P = .35, for cardiac fibrosis and for any cardiac disease, respectively). The cumulative incidence probabilities of cross-sectionally reported side effects with a score of 2 or greater at 15 years were 0.1% (95% CI = 0.0% to 0.5%) vs 0.8% (95% CI = 0.4% to 1.4%) for pulmonary (P = .02), 1.8% (95% CI = 1.1% to 2.8%) vs 2.6% (95% CI = 1.8% to 3.7%) for cardiac (P = .15), and 0.0% (95% CI not evaluated) vs 0.1% (95% CI = 0.0% to 0.4%) for esophageal (P = .16), respectively. No difference was observed in the incidence of second malignancies, contralateral breast cancer, or cardiovascular deaths.The incidence of late pulmonary side effects was statistically significantly higher after IM-MS lymph node irradiation, as were some of the cardiac events, without a difference between left- and right-sided treatments. Absolute rates and differences were very low, without increased non-breast cancer-related mortality, even before introducing heart-sparing techniques." @default.
• W3183282470 created "2021-08-02" @default.
• W3183282470 creator A5002654067 @default.
• W3183282470 creator A5011326151 @default.
• W3183282470 creator A5023510680 @default.
• W3183282470 creator A5024839948 @default.
• W3183282470 creator A5029444442 @default.
• W3183282470 creator A5032383285 @default.
• W3183282470 creator A5036702560 @default.
• W3183282470 creator A5037951488 @default.
• W3183282470 creator A5039811619 @default.
• W3183282470 creator A5041507787 @default.
• W3183282470 creator A5043441210 @default.
• W3183282470 creator A5046853252 @default.
• W3183282470 creator A5047389535 @default.
• W3183282470 creator A5050884991 @default.
• W3183282470 creator A5068220065 @default.
• W3183282470 creator A5068893119 @default.
• W3183282470 creator A5073631057 @default.
• W3183282470 creator A5076237529 @default.
• W3183282470 creator A5085477793 @default.
• W3183282470 creator A5091353600 @default.
• W3183282470 date "2021-07-28" @default.
• W3183282470 modified "2023-10-13" @default.
• W3183282470 title "Side Effects 15 Years After Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925" @default.
• W3183282470 cites W1770259999 @default.
• W3183282470 cites W1903873778 @default.
• W3183282470 cites W1978537515 @default.
• W3183282470 cites W1994715297 @default.
• W3183282470 cites W1997153807 @default.
• W3183282470 cites W2019297220 @default.
• W3183282470 cites W2022685402 @default.
• W3183282470 cites W2036934183 @default.
• W3183282470 cites W2062616726 @default.
• W3183282470 cites W2094827926 @default.
• W3183282470 cites W2100025800 @default.
• W3183282470 cites W2129825983 @default.
• W3183282470 cites W2154375587 @default.
• W3183282470 cites W2168517539 @default.
• W3183282470 cites W2176010689 @default.
• W3183282470 cites W2332829713 @default.
• W3183282470 cites W2343555240 @default.
• W3183282470 cites W2397212311 @default.
• W3183282470 cites W2520230173 @default.
• W3183282470 cites W2555331202 @default.
• W3183282470 cites W2574924994 @default.
• W3183282470 cites W2598117381 @default.
• W3183282470 cites W2765423993 @default.
• W3183282470 cites W2775194658 @default.
• W3183282470 cites W2788151071 @default.
• W3183282470 cites W2899170819 @default.
• W3183282470 cites W2932091339 @default.
• W3183282470 cites W2991031472 @default.
• W3183282470 cites W3080255616 @default.
• W3183282470 cites W3097739674 @default.
• W3183282470 cites W4293107555 @default.
• W3183282470 cites W4301375229 @default.
• W3183282470 cites W993406450 @default.
• W3183282470 doi "https://doi.org/10.1093/jnci/djab113" @default.
• W3183282470 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34320651" @default.
• W3183282470 hasPublicationYear "2021" @default.
• W3183282470 type Work @default.
• W3183282470 sameAs 3183282470 @default.
• W3183282470 citedByCount "25" @default.
• W3183282470 countsByYear W31832824702021 @default.
• W3183282470 countsByYear W31832824702022 @default.
• W3183282470 countsByYear W31832824702023 @default.
• W3183282470 crossrefType "journal-article" @default.
• W3183282470 hasAuthorship W3183282470A5002654067 @default.
• W3183282470 hasAuthorship W3183282470A5011326151 @default.
• W3183282470 hasAuthorship W3183282470A5023510680 @default.
• W3183282470 hasAuthorship W3183282470A5024839948 @default.
• W3183282470 hasAuthorship W3183282470A5029444442 @default.
• W3183282470 hasAuthorship W3183282470A5032383285 @default.
• W3183282470 hasAuthorship W3183282470A5036702560 @default.
• W3183282470 hasAuthorship W3183282470A5037951488 @default.
• W3183282470 hasAuthorship W3183282470A5039811619 @default.
• W3183282470 hasAuthorship W3183282470A5041507787 @default.
• W3183282470 hasAuthorship W3183282470A5043441210 @default.
• W3183282470 hasAuthorship W3183282470A5046853252 @default.
• W3183282470 hasAuthorship W3183282470A5047389535 @default.
• W3183282470 hasAuthorship W3183282470A5050884991 @default.
• W3183282470 hasAuthorship W3183282470A5068220065 @default.
• W3183282470 hasAuthorship W3183282470A5068893119 @default.
• W3183282470 hasAuthorship W3183282470A5073631057 @default.
• W3183282470 hasAuthorship W3183282470A5076237529 @default.
• W3183282470 hasAuthorship W3183282470A5085477793 @default.
• W3183282470 hasAuthorship W3183282470A5091353600 @default.
• W3183282470 hasBestOaLocation W31832824701 @default.
• W3183282470 hasConcept C120665830 @default.
• W3183282470 hasConcept C121332964 @default.
• W3183282470 hasConcept C121608353 @default.
• W3183282470 hasConcept C126322002 @default.
• W3183282470 hasConcept C141071460 @default.
• W3183282470 hasConcept C143998085 @default.
• W3183282470 hasConcept C2779223589 @default.
• W3183282470 hasConcept C2780849966 @default.
• W3183282470 hasConcept C44249647 @default.

• next